Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,447 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,430
Recruiting: 778
Ph III recruiting: 109
Growth YoY: +19.8%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07181720	CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors	suspended	Phase 1	90	Chongqing Precision Biotech Co., LtdINDUSTRY	1	Sep 11, 2026	clinicaltrials
NCT04266730	Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab(PANDA-VAC)	suspended	Phase 1	6	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Apr 23, 2026